<unk> , sold under the brand name Soliqua 100/33 among others, is a fixed-dose combination medication that combines insulin<unk>  and<unk>  and is used to treat diabetes. The most common side effects include hypoglycemia (low blood glucose), diarrhea, vomiting and nausea (feeling sick).<unk>  was approved for medical use in the United States in November 2016, and in the European Union in January 2017.
Insulin glargine/lixisenatide
Insulin degludec/liraglutide
Insulin degludec/insulin aspart
Insulin glulisine
NPH insulin
Glibenclamide/metformin
Insulin detemir
Lente insulin